Genworth Financial, Inc.

Genworth Financial, Inc. (GNW) Market Cap

Genworth Financial, Inc. has a market capitalization of $3.38B.

Financials based on reported quarter end 2025-12-31

Price: $8.72

0.15 (1.75%)

Market Cap: 3.38B

NYSE · time unavailable

CEO: Thomas Joseph McInerney

Sector: Financial Services

Industry: Insurance - Life

IPO Date: 2004-05-25

Website: https://www.genworth.com

Genworth Financial, Inc. (GNW) - Company Information

Market Cap: 3.38B · Sector: Financial Services

Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.

Analyst Sentiment

100%
Strong Buy

Based on 1 ratings

Consensus Price Target

No data available

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 GENWORTH FINANCIAL INC (GNW) — Investment Overview

🧩 Business Model Overview

Genworth Financial Inc (NYSE: GNW) operates as a diversified insurance holding company, serving customers primarily in the United States. Genworth’s primary mission is to help families navigate the financial challenges of aging, with a focus on long-term care (LTC) insurance, mortgage insurance, and other life and annuity products. The company is structured into several business segments designed to cater to different aspects of consumer financial security and protection needs. Through its insurance underwriting, product management, and risk expertise, Genworth is positioned as a critical component in retirement planning and homeownership support.

💰 Revenue Streams & Monetisation Model

Genworth’s principal sources of revenue are derived from several interlinked insurance verticals: - Long-Term Care Insurance: Premium income from LTC insurance products remains a core revenue driver, aimed at covering policyholders for expenses associated with chronic illnesses, disabilities, or other long-term health conditions. - Mortgage Insurance: Genworth’s U.S. mortgage insurance business provides private mortgage insurance (PMI) to mortgage lenders, protecting lenders against borrower default on low downpayment loans. Revenue is generated via periodic premium payments from policyholders or loan originators. - Life Insurance & Fixed Annuities: Though the prominence of these products has evolved, they continue to provide revenue streams through premium payments and spreads between investment income and claims or annuity payouts. - Investment Income: Like many insurers, Genworth invests its float (i.e., collected premiums prior to payout), generating investment returns from a diversified bond, mortgage, and fixed income portfolio, which also contributes significantly to total income. Fee-based services, policy endorsements, and reinsurance arrangements offer supplemental, though modest, sources of revenue.

🧠 Competitive Advantages & Market Positioning

Genworth commands a niche position in U.S. long-term care insurance — a segment characterized by high barriers to entry due to actuarial complexity, regulatory scrutiny, and substantial reserve requirements. The company is one of the longest-standing providers in LTC, with a scale advantage in risk data, claims management, and policyholder servicing. In the mortgage insurance business, Genworth benefits from a large and diversified portfolio and long-standing relationships with stakeholders across the housing finance chain. The company’s digital underwriting capabilities, risk analytics, and loss mitigation strategies enable competitive pricing and adaptability to evolving credit cycles. Genworth’s experience in navigating challenging regulatory environments, restructuring legacy liabilities, and engaging with state insurance departments further distinguishes its management depth. However, legacy issues in long-term care, notably related to reserve adequacy, have shaped both its risk tolerance and industry expertise.

🚀 Multi-Year Growth Drivers

Several secular and cyclical trends are poised to drive growth for Genworth: - Aging U.S. Demographics: An expanding elderly population increases demand for long-term care products, positioning Genworth to benefit as one of the sector’s primary providers. - Homeownership Trends & Mortgage Credit Expansion: As housing affordability and new home purchases drive demand for low downpayment loans, the mortgage insurance business stands to capitalize on higher origination volumes and penetration among first-time homebuyers. - Product Innovation & Rate Approvals: Successfully obtaining new premium rate increases and innovating LTC product designs can help better match pricing to future risks and enhance profitability. - Balance Sheet Restructuring: The run-off and possible transfer of legacy blocks of business, de-leveraging, and capital allocation initiatives can unlock shareholder value and improve financial strength. - Digital Transformation: Enhanced underwriting, customer servicing, and operational cost controls via digitalization can lower loss ratios and drive sustainable earnings accretion.

⚠ Risk Factors to Monitor

Despite its multi-decade franchise, Genworth is exposed to material risks, including: - Long-Term Care Reserve Adequacy: Historical underpricing and evolving morbidity trends mean legacy blocks may require periodic reserve strengthening, pressuring profits and capital. - Regulatory Intervention: Insurance operations are subject to intense regulatory scrutiny; the ability to secure premium rate increases is not guaranteed and varies by jurisdiction. - Interest Rate Sensitivity: As a long-dated liability writer, Genworth’s reserves and investment portfolio are sensitive to changes in yield curves and investment returns. - Credit Cycle Exposure: The mortgage insurance business is highly exposed to housing cycles, unemployment rates, and macroeconomic downturns, which could drive higher claim frequencies. - Capital Allocation & Legacy Liabilities: The complexity of managing and potentially shedding legacy LTC or life blocks, and litigation or policyholder challenges, require careful navigation. - Competitive Landscape: Increased competition from new entrants in mortgage insurance or alternative products in retirement care could compress margins over time.

📊 Valuation & Market View

Genworth tends to trade at a discount to peers, reflecting investor concerns around long-term care reserve adequacy, capital requirements, and growth visibility in legacy blocks. The company’s valuation is typically benchmarked to book value metrics and sum-of-the-parts approaches, valuing the mortgage insurance franchise at a premium relative to the run-off LTC and life blocks. Prospective upside may stem from asset sales, restructurings, improved profitability in mortgage insurance, or unlocking value through capital management initiatives. However, the discount persists until the market gains comfort with reserve sufficiency and capital flexibility. Changes in interest rates, housing market momentum, and regulatory outcomes may lead to periodic volatility in GNW’s multiples.

🔍 Investment Takeaway

Genworth Financial Inc. represents a complex, multi-faceted insurance investment with both legacy challenges and strategic optionality. Its leadership in mortgage insurance and deep experience in long-term care offer unique niche exposure not easily replicated in the public markets. The company’s fate is shaped by its ability to prudently manage legacy liability risk, realize value from core franchises, and adapt product offerings amidst shifting demographic and economic tides. For risk-tolerant investors seeking discounted exposure to long-term secular themes in U.S. aging and homeownership, Genworth offers an intriguing—though nuanced—special situation. Diligent ongoing assessment of reserve sufficiency, regulatory liaisons, and capital health is critical for portfolio managers considering exposure to GNW.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"GNW (latest quarter ended 2025-12-31) reported Revenue of $1.493B and Net Income of $2.0M (EPS $0.005). On a QoQ basis, revenue fell to $1.493B from $1.873B (−20.3%), while net income collapsed from $116M to $2M (−98.3%). Compared with the prior-year quarter, YoY growth rates were not computable because only one year of quarterly history was provided. Profitability deteriorated materially. Net income margin moved from ~6.2% in 2025-09-30 (116M / 1.873B) to ~0.1% in 2025-12-31 (2M / 1.493B), indicating a sharp profitability contraction across the four-quarter period despite revenue volatility (generally ranging ~$1.42B–$1.87B). Cash flow quality looks better than earnings: free cash flow was $200M in 2025-12-31 (vs. $87M in 2025-09-30). The company paid no dividends in the latest quarter, and dividends remain minimal versus cash generation. Balance sheet resilience appears solid: total assets were ~$88.1B with equity around ~$9.77B and net debt remaining negative (net cash) throughout. Total shareholder return is supported by strong momentum: the stock is up +29.79% over 1 year (dividend yield shown as ~0)."

Revenue Growth

Fair

QoQ revenue declined from $1.873B (2025-09-30) to $1.493B (2025-12-31), −20.3%. Over the four quarters, revenue has been volatile (~$1.42B–$1.87B). YoY growth is not measurable with the provided history.

Profitability

Neutral

Net income fell from $116M to $2M QoQ (−98.3%), with net margin dropping from ~6.2% to ~0.1%. EPS similarly deteriorated ($0.29 to $0.005), indicating contracting profitability.

Cash Flow Quality

Positive

Free cash flow was strong in the latest quarter ($200M) versus $87M prior. However, earnings and cash flow diverged sharply (net income near zero while FCF was positive). Dividends are minimal.

Leverage & Balance Sheet

Good

Balance sheet looks resilient: total assets were ~+$88.1B and total equity ~+$9.77B in the latest quarter. Net debt is consistently negative (net cash position), reducing leverage risk.

Shareholder Returns

Good

Price performance is strong: +29.79% over 1 year, which should materially support total return. Dividend yield is effectively ~0 in the provided ratio data, so capital appreciation is the main driver.

Analyst Sentiment & Valuation

Caution

No current analyst price target was provided. Reported trailing P/E appears distorted in the latest quarter (very high), consistent with the sharp earnings drop; valuation signal is therefore less reliable.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Genworth’s Q4 and 2025 results show a classic split: Enact is generating strong, recurring earnings and capital (Q4 adjusted operating income $146M; $407M proceeds from Enact in 2025), enabling aggressive buybacks ($245M in 2025 plus $38M through Feb 20, 2026). In contrast, the Closed Block remains a material earnings drag—Q4 Closed Block loss $114M and LTC unfavorable A/E of $124M pretax (higher claims, lower terminations). Management also flagged that Closed Block A/E losses could average ~$75M per quarter in 2026, with seasonality potentially worsening through the year. The only Q&A question focused on the rationale for investing in both CareScout services and insurance. Management’s tone was confident and market-framed (fragmented LTC ecosystem; services driving affordability via Quality Network discounts; services serving baby boomers who did not buy LTC insurance). However, the financials underscore that analyst pressure likely centers on whether CareScout can offset Closed Block volatility fast enough—management did not provide hard CareScout financial proof beyond match/revenue targets.

AI IconGrowth Catalysts

  • Enact continued strong execution: $146 million adjusted operating income in Q4; net reserve release of $60 million driving 7% loss ratio
  • CareScout match growth: 925 matches in Q4; 3,255 matches in 2025 vs 2,500 original target and 3,000 updated estimate (3x vs 2024)
  • CareScout Quality Network scale: ~790 home care providers, 1,000+ locations, covering 97% of population age 65+
  • CareScout launched Care Assurance (stand-alone LTC insurance) and is live in 40 states (4 additional pending)

Business Development

  • Acquisition of Seniorly closed in Q4; integration expanding direct-to-consumer reach (credentialing of major national senior living providers expected complete by end of 2026)
  • Expanded partnerships with employee assistance programs (EAPs) and carriers; referral volumes exceeded expectations in 2025
  • Care plans now deliver both in-person and virtually nationwide (distribution across carrier/employer/EAP audiences)

AI IconFinancial Highlights

  • Reported net income: $2 million; adjusted operating income: $8 million in Q4
  • Segment results: Enact adjusted operating income $146 million; Closed Block adjusted operating loss $114 million; Corporate & Other adjusted operating loss $24 million
  • Closed Block LTC drivers: adjusted operating loss $159 million from liability remeasurement loss tied to A/E variances and unfavorable assumption updates
  • Unfavorable LTC A/E: $124 million pretax, driven primarily by higher claims and lower terminations in capped cohorts
  • Full-year adjusted operating income to Genworth: $144 million; Enact contribution: $558 million (proportional to strong Enact cash generation)
  • Full-year Closed Block adjusted operating loss: $317 million (LTC: $326 million; Life: -$66 million; Annuities: +$75 million)
  • Annual assumption review impact (Closed Block): net unfavorable adjusted operating loss of $6 million after tax; $47 million pretax net unfavorable from LTC healthy life and cost-of-care inflation updates
  • Statutory pretax income (U.S. life insurers): ~$71 million for full year (vs prior year including $355 million LTC legal settlements largely complete by end of 2024)

AI IconCapital Funding

  • Holding company liquidity: $234 million cash and liquid assets at quarter-end
  • 2025 share repurchases: $245 million (including $94 million in Q4 at avg $8.66/share); additional $38 million repurchased through Feb 20, 2026
  • Share count reduction: ~511 million to ~388 million (down ~24%) since May 2022
  • 2026 share repurchase allocation guidance: $175 million to $225 million
  • Debt: retired ~$7 million principal in 2025 for $6 million cash; holding company debt ended at ~$783 million
  • Debt service coverage ratio: ~8x cash interest coverage

AI IconStrategy & Ops

  • Care Assurance resegmentation / closed block presentation change: ceased LTC sales in GLIC; new policies issued from CareScout; reporting moved under new Closed Block segment (economics unchanged)
  • LTC risk mitigation toolkit: benefit reductions + premium rate increases remain primary levers
  • In-force rate action program (MYRAP): $34.5 billion net present value recognized since 2012; $1 billion related to rate increases in 2025 (approvals lower than recent years per management)
  • Risk exposure reduction: 5% compound benefit inflation option exposure reduced to <36% from 57% in 2014; policies with lifetime benefits decreased to 11%
  • Closed Block mitigation via CareScout: expected NPV claim savings of $1.0B–$1.5B from CareScout Quality Network provider discounts; Live Well | Age Well engagement driving claim delay and potential referral to Quality Network

AI IconMarket Outlook

  • Enact capital return guidance for 2026: Enact expects to return ~$500 million; Genworth expects to receive ~ $405 million (81% ownership)
  • CareScout services targets: ~7,500 matches in 2026 (home care + assisted living)
  • CareScout services revenue guidance: at least $25 million in 2026
  • CareScout services investment guidance: invest ~$50 million to ~$55 million in 2026
  • CareScout insurance growth expectation: adoption expected to build gradually (no explicit sales guidance provided)
  • Closed Block 2026 earnings pattern: A/E losses could average ~$75 million per quarter; seasonality expected net favorable mortality impacts in Q1 that worsen through the remainder of the year
  • AXA litigation: Court of Appeal hearing set for July 21–23; decision expected within ~3–6 months; if upheld, total recoveries expected ~ $750 million (noting exchange-rate sensitivity)

AI IconRisks & Headwinds

  • Closed Block LTC unfavorable experience: Q4 pretax unfavorable LTC A/E of $124 million (higher claims and lower terminations in capped cohorts)
  • Assumption updates headwind: $47 million pretax net unfavorable impact from LTC healthy life / near-term cost-of-care inflation assumption updates (offset by termination and future rate/benefit outlook improvements)
  • Ongoing Closed Block earnings volatility risk: A/E losses averaged ~$75 million per quarter in 2025 and could continue at that level in 2026; results may vary with seasonality
  • CareScout scaling risk implicit in guidance framing: management reiterated breakeven will take time to scale businesses (no near-term breakeven date provided)

Sentiment: MIXED

Note: This summary was synthesized by AI from the GNW Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (GNW)

© 2026 Stock Market Info — Genworth Financial, Inc. (GNW) Financial Profile
Genworth Financial, Inc. (GNW) Market Cap, Stock Analysis & Valuation